Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/26/2025

Management of Symptomatic Gallstones

Urgency Based on Clinical Presentation

  • For severe gallstone pancreatitis, urgent therapeutic ERCP with sphincterotomy should be performed within the first 72 hours after onset of pain, especially with cholangitis, jaundice, or dilated common bile duct 1
  • For gallbladder perforation, early diagnosis and immediate surgical intervention are critical to decrease morbidity and mortality rates, which can be as high as 12-16% 2

Management Algorithm

Initial Assessment

  • Determine severity of presentation (uncomplicated symptomatic gallstones vs. acute cholecystitis vs. gallstone pancreatitis) 1
  • For severe acute pancreatitis, manage in high dependency or intensive care unit with full monitoring 1

Timing of Intervention

  • For mild cases, perform laparoscopic cholecystectomy within 2-4 weeks, preferably during the same hospital admission 1
  • Delaying definitive treatment beyond two weeks after discharge increases risk of potentially fatal recurrent acute pancreatitis 3
  • In severe gallstone pancreatitis, delay cholecystectomy until signs of lung injury and systemic disturbance have resolved 1, 3
  • For patients with infected pancreatic necrosis, intervention is required to debride all cavities containing necrotic material 3

Special Populations

  • For high-risk patients unfit for surgery, percutaneous cholecystostomy is a safe and effective treatment for acute cholecystitis 2
  • Endoscopic sphincterotomy alone is adequate treatment for unfit patients with gallstone pancreatitis 3

Surgical Considerations

  • Laparoscopic cholecystectomy is the first-line treatment for symptomatic gallstones 4
  • Benefits include immediate and permanent stone removal with lower complication rates compared to open cholecystectomy 4
  • Mortality rates vary by age and comorbidities, with a rate of 0.054% for low-risk women under 49 4
  • Mortality rates are higher for men (approximately twice that of women) and increase with age and presence of systemic disease 4

Common Pitfalls and Caveats

  • Failure to recognize risk factors for conversion to open cholecystectomy, including age >65 years, male gender, acute cholecystitis, thickened gallbladder wall, diabetes mellitus, and previous upper abdominal surgery 2
  • Delaying cholecystectomy beyond two weeks after discharge increases risk of potentially fatal recurrent acute pancreatitis 3
  • Failing to perform ERCP in patients with cholangitis or biliary obstruction can lead to increased morbidity and mortality 1
  • Bile duct injury is a potential complication of laparoscopic cholecystectomy, making surgeon experience crucial 4

Non-Surgical Options

  • For patients unfit for surgery, alternatives include oral bile acids (ursodeoxycholic acid or chenodeoxycholic acid) for select patients with small stones and patent cystic duct 4
  • Percutaneous cholecystostomy with possible long-term drainage is an option for high-risk patients 2
  • Endoscopic sphincterotomy is an option for patients with gallstone pancreatitis who cannot undergo cholecystectomy 1

REFERENCES